Login / Signup

Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.

Jens WiebeFelix J HofmannNick WestAndreas BaumbachDidier CarrieEduardo Pinar BermudezGuillaume CaylaFelipe Hernandez HernandezJose M de la Torre HernandezRené KoningBruno LoiElisabetta MoscarellaGiuseppe TarantiniAzfar ZamanChristiane LoberThomas RiemerStephan AchenbachChristian W HammHolger M Nefnull null
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
The EAC demonstrates reasonable real-world clinical outcome data after BVS implantation. However, the rate of scaffold thrombosis remains high.
Keyphrases
  • clinical practice
  • tissue engineering
  • pulmonary embolism
  • electronic health record
  • physical activity
  • big data
  • type diabetes
  • machine learning
  • adipose tissue
  • data analysis